Epirus Biophramaceuticals Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BTIG initiated coverage on United Therapeutics Corporation (NASDAQ: UTHR) Monday with a Neutral rating.
Analyst Hartaj Singh believed a “late-2017 patent cliff for 3 out of 4 of its top products that could reduce 2018 adjusted EPS to 2013 levels (~$6-7/share) is offset by the blue sky. Read More. ....

Hartaj Singh , Amit Munshi , Alexion Pharmaceuticalstuesday , Goldman Sachs , Edward Tenthoff , Oppenheimer Hartaj Singh , Arqule Stocktuesday , Alexion Pharmawednesday , Astellas Pharma , Salveen Richter , Inovio Pharmaceuticals Inc , Arqule Inc , Hours Center , Sunesis Pharmaceuticals Inc , Company Unique Industry Positionwednesday , Moderna Inc , Sarepta Therapeutics Inc , Alexion Pharmaceuticals , Initiates Coverage On Sunesis Pharmaceuticals , United Therapeutics Corporation , Drug Administration , Alexion Pharmaceuticals Inc , Fund Stake Prop Up Stock , Epirus Biophramaceuticals Inc , Pharmacyclics Inc , Medivation Inc ,